KRTAP8-2P

Across TCGA pan-cancer cohorts, KRTAP8-2P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of KRTAP8-2P’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where KRTAP8-2P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRTAP8-2P is over-expressed in tumor.

BLCA and THCA are the cancer types where KRTAP8-2P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KRTAP8-2P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	III,IV	+0.145	.046	3	view →
THCA	All	All	+0.088	.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

KRTAP8-2P–BLCA

Open the BLCA breakdown →